It’s clear there’s no reason for optimism that H5N1 will fade away as a minor nuisance. To the contrary, the situation has only been trending worse.

India's apex health research body has warned that H5N1 infection in humans has a high case fatality rate, exceeding 50 ...

A recent study published in Nature Communications by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) and collaborators evaluated a replicating RNA (repRNA) vaccine ...

The Trump administration would do well to follow the lead of Maryland, which is taking decisive action to stop the spread of ...

Hologic's Panther system, on which the assay runs, processes the samples, delivering initial outcomes in under three hours.

Scientists have uncovered a blood-based molecular signature that can predict vaccine durability. Could this change ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

As cases of seasonal influenza surge, health officials are closely monitoring a growing threat—the potential fusion of human and bird flu strains.

There are two main variants of H5N1 that researchers are monitoring ... But a single mutation in the virus’s RNA could change this preference, making it easier for the virus to bind to a ...

The H5N1 outbreak has resulted in 67 confirmed human ... which is developing a flu vaccine using similar messenger RNA-based technology as its Covid jab. The Seqirus jab has been ordered by ...

The Allegheny Front’s Kara Holsopple talked about the risks with Dr. Justin Brown, DVM, PhD, a Penn State professor and ...